Insider Trading activities of Ligand Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ligand Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ligand Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Ligand Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is LGND. The reporting company's CIK number is 886163.
The total value of stock buying since 2005 is $46,080,298.
The total value of stock sales since 2005 is $337,446,728.
The total value of stock option exercises since 2005 is $19,691,325.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Ligand Pharmaceuticals Inc (LGND).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-10 0 $0 17,000 $4,609,147 25,071 $803,355
2018-09 0 $0 42,565 $10,841,870 43,609 $1,706,916
2018-08 0 $0 135,586 $33,032,473 54,545 $1,657,341
2018-07 0 $0 2,500 $518,700 0 $0
2018-06 0 $0 4,000 $778,040 4,000 $50,120
2018-05 0 $0 21,286 $3,721,176 22,341 $321,633
2018-04 0 $0 2,500 $401,062 0 $0
2018-03 0 $0 11,457 $1,967,012 3,335 $33,750
2018-02 0 $0 35,031 $5,391,983 6,448 $78,794
2018-01 0 $0 53,099 $8,387,128 16,249 $262,258
2017-12 0 $0 925 $126,956 0 $0
2017-11 0 $0 47,486 $6,692,465 4,000 $40,480
2017-10 0 $0 0 $0 11,384 $249,537
2017-09 0 $0 5,000 $650,000 5,000 $105,000
2017-08 0 $0 32,208 $4,083,845 12,433 $184,434
2017-06 0 $0 16,666 $1,938,360 16,666 $349,986
2017-05 0 $0 42,868 $4,756,013 7,821 $77,975
2017-03 0 $0 14,879 $1,575,852 24,554 $246,056
2017-02 0 $0 32,000 $3,403,060 0 $0
2016-11 0 $0 24,809 $2,649,486 0 $0
2016-10 0 $0 0 $0 13,980 $713,776
2016-09 0 $0 5,666 $642,339 0 $0
2016-08 0 $0 13,500 $1,664,550 16,625 $165,751
2016-07 0 $0 1,000 $121,080 0 $0
2016-06 0 $0 1,000 $118,335 0 $0
2016-05 0 $0 26,334 $3,141,942 0 $0
2016-04 0 $0 5,000 $575,000 0 $0
2016-03 0 $0 23,362 $2,351,622 14,650 $212,240
2016-01 0 $0 1,666 $158,443 1,666 $98,960
2015-11 0 $0 10,719 $1,084,089 7,719 $285,170
2015-08 0 $0 58,666 $5,714,669 19,670 $241,508
2015-07 0 $0 14,067 $1,393,519 15,067 $225,561
2015-06 0 $0 51,311 $4,961,059 44,171 $539,932
2015-05 0 $0 77,603 $6,544,730 68,363 $2,421,102
2015-03 0 $0 16,390 $1,213,941 5,264 $95,778
2015-02 0 $0 2,810 $159,080 0 $0
2014-12 275 $12,436 0 $0 0 $0
2014-10 13,085 $568,067 0 $0 10,835 $268,340
2014-09 0 $0 0 $0 20,300 $227,075
2014-08 1,000 $54,970 0 $0 0 $0
2014-06 855 $37,440 1,100 $76,648 1,100 $14,509
2014-05 0 $0 7,166 $479,548 2,499 $38,609
2014-03 0 $0 90,726 $6,473,775 5,000 $44,850
2014-02 0 $0 647,729 $48,234,399 146,653 $2,318,526
2014-01 0 $0 15,000 $960,000 9,000 $189,000
2013-12 293 $9,936 12,700 $694,288 6,700 $66,792
2013-11 0 $0 528,628 $30,270,074 2,327 $21,887
2013-10 0 $0 10,000 $550,000 10,518 $163,291
2013-09 0 $0 519,023 $23,460,683 0 $0
2013-08 0 $0 60,406 $2,717,295 70,254 $983,542
2013-06 2,043 $35,465 0 $0 0 $0
2013-05 0 $0 4,000 $106,640 0 $0
2013-01 39,600 $783,169 0 $0 0 $0
2012-12 57,856 $1,042,021 0 $0 3,333 $40,195
2012-11 0 $0 120,000 $2,351,670 0 $0
2012-10 16,591 $252,023 0 $0 0 $0
2012-09 0 $0 4,249 $79,753 0 $0
2012-08 3,243 $53,070 0 $0 0 $0
2012-06 700 $8,386 0 $0 0 $0
2012-05 198,500 $2,306,600 196,000 $2,277,520 0 $0
2012-03 0 $0 3,606 $56,841 0 $0
2011-11 522,540 $5,573,125 0 $0 0 $0
2011-10 114,473 $1,556,366 0 $0 0 $0
2011-09 10,000 $152,100 0 $0 0 $0
2011-08 1,049,704 $11,951,656 0 $0 0 $0
2011-05 1,725 $18,906 0 $0 0 $0
2011-03 61,900 $650,373 0 $0 0 $0
2011-02 151,500 $1,510,915 94,966 $944,779 0 $0
2010-11 10,000 $15,950 0 $0 0 $0
2010-06 5,000 $7,400 0 $0 0 $0
2010-05 27,145 $42,622 0 $0 0 $0
2010-03 0 $0 1,060,246 $1,849,987 0 $0
2010-02 6,000 $10,020 0 $0 0 $0
2009-12 0 $0 2,000 $4,300 0 $0
2009-08 0 $0 4,552,550 $11,700,053 0 $0
2009-07 0 $0 142,700 $423,676 0 $0
2009-06 0 $0 829,265 $2,416,889 0 $0
2009-04 826,600 $2,149,160 438,800 $2,018,479 0 $0
2009-02 826,600 $2,149,160 832,600 $3,818,079 0 $0
2009-01 43,736 $87,472 0 $0 0 $0
2008-12 477,022 $917,374 0 $0 0 $0
2008-11 3,286,305 $5,733,879 0 $0 0 $0
2008-05 515,300 $1,749,335 512,300 $1,739,258 0 $0
2008-03 3,000 $10,971 0 $0 0 $0
2007-11 2,000 $8,560 0 $0 0 $0
2007-08 7,000 $42,280 0 $0 0 $0
2007-06 402,100 $2,748,083 400,100 $2,734,683 0 $0
2007-05 8,350 $54,108 0 $0 0 $0
2007-04 0 $0 0 $0 10,005 $42,391
2007-03 0 $0 5,720,000 $60,288,799 0 $0
2006-12 350,000 $3,776,900 217,783 $2,383,342 217,783 $1,707,269
2006-11 0 $0 260,570 $2,966,244 263,350 $2,390,764
2006-03 0 $0 0 $0 1,841 $6,872

Table 2. Detailed insider stock purchases, sales, and option exercises of Ligand Pharmaceuticals Inc insiders (LGND)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-10-24 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 3,900 18.20 70,960
2018-10-12 Davis Todd C (Director) Option Ex 5,083 104.53 531,300
2018-10-11 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 2,000 14.47 28,940
2018-10-08 Davis Todd C (Director) Sale 2,500 253.99 634,977
2018-10-01 Foehr Matthew W (President and COO) Sale 12,000 273.88 3,286,560
2018-10-01 Foehr Matthew W (President and COO) Option Ex 14,088 12.22 172,155
2018-10-01 Kozarich John W (Director) Sale 2,500 275.04 687,610
2018-09-17 Berkman Charles S (SVP, Gen. Counsel & Secretary) Sale 2,813 250.69 705,182
2018-09-17 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 2,813 100.38 282,368
2018-09-04 Sabba Stephen L (Director) Sale 5,000 255.05 1,275,250
2018-09-04 Sabba Stephen L (Director) Option Ex 5,000 13.23 66,150
2018-09-04 Berkman Charles S (SVP, Gen. Counsel & Secretary) Sale 19,417 254.99 4,951,063
2018-09-04 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 19,417 59.60 1,157,214
2018-09-04 Foehr Matthew W (President and COO) Sale 12,000 255.01 3,060,084
2018-09-04 Foehr Matthew W (President and COO) Option Ex 13,044 12.22 159,397
2018-09-04 Lamattina John L (Director) Sale 3,335 254.96 850,291
2018-09-04 Lamattina John L (Director) Option Ex 3,335 12.53 41,787
2018-08-30 Higgins John L (Chief Executive Officer) Sale 3,500 258.25 903,875
2018-08-29 Korenberg Matthew E (EVP,Finance & Strategy and CFO) Sale 18,357 256.69 4,712,058
2018-08-29 Korenberg Matthew E (EVP,Finance & Strategy and CFO) Option Ex 11,540 85.79 990,016
2018-08-17 Davis Todd C (Director) Sale 3,167 239.50 758,496
2018-08-17 Aryeh Jason (Director) Sale 26,862 241.81 6,495,553
2018-08-17 Higgins John L (Chief Executive Officer) Sale 12,993 243.00 3,157,299
2018-08-17 Higgins John L (Chief Executive Officer) Option Ex 12,993 14.47 188,008
2018-08-16 Patel Sunil (Director) Sale 42,287 240.05 10,150,825
2018-08-16 Patel Sunil (Director) Option Ex 27,005 16.14 435,806
2018-08-16 Davis Todd C (Director) Sale 5,833 239.93 1,399,505
2018-08-16 Aryeh Jason (Director) Sale 1,080 245.00 264,600
2018-08-16 Higgins John L (Chief Executive Officer) Sale 21,507 241.33 5,190,262
2018-08-16 Higgins John L (Chief Executive Officer) Option Ex 3,007 14.47 43,511
2018-07-02 Kozarich John W (Director) Sale 2,500 207.48 518,700
2018-06-04 Lamattina John L (Director) Sale 4,000 194.51 778,040
2018-06-04 Lamattina John L (Director) Option Ex 4,000 12.53 50,120
2018-05-15 Higgins John L (Chief Executive Officer) Sale 12,405 179.97 2,232,490
2018-05-15 Higgins John L (Chief Executive Officer) Option Ex 12,405 16.14 200,216
2018-05-10 Foehr Matthew W (President and COO) Sale 8,881 167.63 1,488,686
2018-05-10 Foehr Matthew W (President and COO) Option Ex 9,936 12.22 121,417
2018-04-02 Kozarich John W (Director) Sale 2,500 160.43 401,062
2018-03-12 Sabba Stephen L (Director) Sale 622 180.73 112,414
2018-03-09 Aryeh Jason (Director) Sale 4,000 176.47 705,900
2018-03-08 Aryeh Jason (Director) Sale 3,500 174.88 612,094
2018-03-05 Lamattina John L (Director) Sale 3,335 160.90 536,604
2018-03-05 Lamattina John L (Director) Option Ex 3,335 10.12 33,750
2018-02-27 Davis Todd C (Director) Sale 12,335 151.90 1,873,711
2018-02-26 Davis Todd C (Director) Sale 4,835 153.57 742,535
2018-02-23 Aryeh Jason (Director) Sale 3,417 155.00 529,635
2018-02-23 Foehr Matthew W (President and COO) Sale 5,444 152.98 832,823
2018-02-23 Foehr Matthew W (President and COO) Option Ex 6,448 12.22 78,794
2018-02-15 Higgins John L (Chief Executive Officer) Sale 9,000 157.03 1,413,279
2018-01-24 Higgins John L (Chief Executive Officer) Sale 22,500 165.00 3,712,500
2018-01-19 Higgins John L (Chief Executive Officer) Sale 28,099 153.46 4,312,128
2018-01-19 Higgins John L (Chief Executive Officer) Option Ex 16,249 16.14 262,258
2018-01-10 Kozarich John W (Director) Sale 2,500 145.00 362,500
2017-12-20 Sabba Stephen L (Director) Sale 925 137.25 126,956
2017-11-17 Korenberg Matthew E (VP, Finance and CFO) Sale 6,559 142.63 935,510
2017-11-17 Aryeh Jason (Director) Sale 24,400 140.22 3,421,368
2017-11-17 Lamattina John L (Director) Sale 4,000 139.79 559,160
2017-11-17 Lamattina John L (Director) Option Ex 4,000 10.12 40,480
2017-11-17 Higgins John L (Chief Executive Officer) Sale 2,258 140.34 316,887
2017-11-16 Kozarich John W (Director) Sale 5,000 141.71 708,550
2017-11-16 Higgins John L (Chief Executive Officer) Sale 5,269 142.53 750,990
2017-10-13 Higgins John L (Chief Executive Officer) Option Ex 11,384 21.92 249,537
2017-09-05 Higgins John L (Chief Executive Officer) Sale 5,000 130.00 650,000
2017-09-05 Higgins John L (Chief Executive Officer) Option Ex 5,000 21.00 105,000
2017-08-23 Aryeh Jason Sale 2,000 127.99 255,980
2017-08-09 Berkman Charles S (VP, Gen. Counsel & Secretary) Sale 18,625 126.96 2,364,667
2017-08-09 Foehr Matthew W (President and COO) Sale 6,100 127.51 777,823
2017-08-09 Foehr Matthew W (President and COO) Option Ex 6,950 9.97 69,291
2017-08-08 Higgins John L (Chief Executive Officer) Sale 5,483 125.00 685,375
2017-08-08 Higgins John L (Chief Executive Officer) Option Ex 5,483 21.00 115,143
2017-06-21 Higgins John L (Chief Executive Officer) Sale 4,666 120.00 559,920
2017-06-21 Higgins John L (Chief Executive Officer) Option Ex 4,666 21.00 97,986
2017-06-09 Higgins John L (Chief Executive Officer) Sale 12,000 114.87 1,378,440
2017-06-09 Higgins John L (Chief Executive Officer) Option Ex 12,000 21.00 252,000
2017-05-15 Foehr Matthew W (President and COO) Option Ex 2,200 9.97 21,934
2017-05-12 Aryeh Jason (Director) Sale 14,582 111.87 1,631,332
2017-05-12 Foehr Matthew W (President and COO) Sale 5,621 112.19 630,648
2017-05-12 Foehr Matthew W (President and COO) Option Ex 5,621 9.97 56,041
2017-05-11 Aryeh Jason (Director) Sale 22,665 110.04 2,494,033
2017-03-20 Higgins John L (Chief Executive Officer) Sale 4,000 109.10 436,400
2017-03-08 Higgins John L (Chief Executive Officer) Sale 4,000 107.06 428,240
2017-03-08 Higgins John L (Chief Executive Officer) Option Ex 15,675 10.05 157,533
2017-03-03 Foehr Matthew W (President and COO) Option Ex 2,000 9.97 19,940
2017-03-02 Foehr Matthew W (President and COO) Sale 6,879 103.39 711,212
2017-03-02 Foehr Matthew W (President and COO) Option Ex 6,879 9.97 68,583
2017-02-28 Aryeh Jason (Director) Sale 7,000 107.58 753,060
2017-02-27 Aryeh Jason (Director) Sale 25,000 106.00 2,650,000
2016-11-25 Aryeh Jason (Director) Sale 3,478 106.96 372,006
2016-11-22 Aryeh Jason (Director) Sale 15,001 107.40 1,611,062
2016-11-18 Aryeh Jason (Director) Sale 5,000 105.00 525,000
2016-11-16 Aryeh Jason (Director) Sale 1,330 106.33 141,418
2016-10-31 Davis Todd C (Director) Option Ex 13,980 51.06 713,776
2016-09-22 Higgins John L (Chief Executive Officer) Sale 3,000 117.34 352,020
2016-09-07 Kozarich John W (Director) Sale 1,000 115.00 115,000
2016-09-01 Kozarich John W (Director) Sale 1,666 105.23 175,319
2016-08-08 Foehr Matthew W (President and COO) Option Ex 4,125 9.97 41,126
2016-08-05 Foehr Matthew W (President and COO) Sale 12,500 122.14 1,526,750
2016-08-05 Foehr Matthew W (President and COO) Option Ex 12,500 9.97 124,625
2016-08-01 Kozarich John W (Director) Sale 1,000 137.80 137,800
2016-07-01 Kozarich John W (Director) Sale 1,000 121.08 121,080
2016-06-01 Kozarich John W (Director) Sale 1,000 118.33 118,335
2016-05-18 Herman Melanie J (Director of Accounting) Sale 334 120.50 40,247
2016-05-06 Aryeh Jason (Director) Sale 15,000 118.52 1,777,830
2016-05-05 Aryeh Jason (Director) Sale 10,000 120.21 1,202,120
2016-05-02 Kozarich John W (Director) Sale 1,000 121.75 121,745
2016-04-06 Kozarich John W (Director) Sale 5,000 115.00 575,000
2016-03-17 Foehr Matthew W (President and COO) Sale 6,400 96.70 618,880
2016-03-17 Foehr Matthew W (President and COO) Option Ex 8,650 9.97 86,240
2016-03-08 Aryeh Jason (Director) Sale 500 102.49 51,245
2016-03-08 Higgins John L (Chief Executive Officer) Option Ex 6,000 21.00 126,000
2016-03-07 Aryeh Jason (Director) Sale 5,629 101.06 568,894
2016-03-07 Higgins John L (Chief Executive Officer) Sale 10,833 102.70 1,112,603
2016-01-20 Kozarich John W (Director) Sale 1,666 95.10 158,443
2016-01-20 Kozarich John W (Director) Option Ex 1,666 59.40 98,960
2015-11-11 Herman Melanie J (Director of Accounting) Sale 7,719 101.00 779,619
2015-11-11 Herman Melanie J (Director of Accounting) Option Ex 7,719 36.94 285,170
2015-11-11 Aryeh Jason (Director) Sale 3,000 101.49 304,470
2015-08-17 Knott David M (Director) Sale 4,000 95.98 383,936
2015-08-13 Knott David M (Director) Sale 36,525 96.20 3,513,558
2015-08-12 Knott David M (Director) Sale 13,275 96.45 1,280,426
2015-08-07 Knott David M (Director) Sale 200 99.02 19,803
2015-08-06 Davis Todd C (Director) Option Ex 19,670 12.28 241,508
2015-08-06 Higgins John L (Chief Executive Officer) Sale 4,666 110.79 516,946
2015-07-13 Berkman Charles S (VP, Gen. Counsel & Secretary) Option Ex 1,000 53.10 53,100
2015-07-10 Berkman Charles S (VP, Gen. Counsel & Secretary) Sale 14,067 99.06 1,393,519
2015-07-10 Berkman Charles S (VP, Gen. Counsel & Secretary) Option Ex 14,067 12.26 172,461
2015-06-29 Foehr Matthew W (President and COO) Option Ex 2,500 9.97 24,925
2015-06-26 Foehr Matthew W (President and COO) Sale 12,500 100.97 1,262,125
2015-06-26 Foehr Matthew W (President and COO) Option Ex 12,500 9.97 124,625
2015-06-22 Foehr Matthew W (President and COO) Sale 23,046 96.56 2,225,252
2015-06-22 Foehr Matthew W (President and COO) Option Ex 25,046 9.97 249,708
2015-06-10 Herman Melanie J (Interim CFO) Sale 4,125 93.50 385,687
2015-06-10 Herman Melanie J (Interim CFO) Option Ex 4,125 34.10 140,674
2015-06-09 Higgins John L (Chief Executive Officer) Sale 10,000 93.60 936,000
2015-06-04 Aryeh Jason (Director) Sale 1,640 92.68 151,995
2015-05-20 Aryeh Jason (Director) Sale 1,000 87.65 87,650
2015-05-19 Aryeh Jason (Director) Sale 2,240 88.82 198,956
2015-05-18 Aryeh Jason (Director) Sale 6,000 86.74 520,439
2015-05-14 Desilva Nishan M (VP, Finance & Strategy and CFO) Sale 20,938 83.84 1,755,441
2015-05-14 Desilva Nishan M (VP, Finance & Strategy and CFO) Option Ex 20,938 74.42 1,558,205
2015-05-13 Desilva Nishan M (VP, Finance & Strategy and CFO) Sale 23,905 83.28 1,990,688
2015-05-13 Desilva Nishan M (VP, Finance & Strategy and CFO) Option Ex 23,905 18.20 434,951
2015-05-12 Desilva Nishan M (VP, Finance & Strategy and CFO) Sale 23,520 84.67 1,991,556
2015-05-12 Desilva Nishan M (VP, Finance & Strategy and CFO) Option Ex 23,520 18.20 427,946
2015-03-19 Patel Sunil (Director) Sale 4,591 74.42 341,662
2015-03-16 Berkman Charles S (VP, Gen. Counsel & Secretary) Sale 11,264 74.56 839,810
2015-03-16 Berkman Charles S (VP, Gen. Counsel & Secretary) Option Ex 5,264 18.20 95,778
2015-03-02 Herman Melanie J (Director of Accounting) Sale 535 60.69 32,469
2015-02-19 Herman Melanie J (Director of Accounting) Sale 510 57.84 29,498
2015-02-10 Desilva Nishan M (VP, Corporate Development) Sale 2,300 56.34 129,582
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of LGND listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ligand Pharmaceuticals Inc (symbol LGND, CIK number 886163) see the Securities and Exchange Commission (SEC) website.